Cargando…
Performance of a high-throughput, automated enzyme immunoassay for the detection of SARS-CoV-2 antigen, including in viral “variants of concern”: Implications for clinical use
Direct detection of SARS-CoV-2 viral antigens could replace RT-PCR, provided that its clinical performance is validated in different epidemiological settings. Here, we evaluated the performance of the VITROS Antigen test, an enzyme immunoassay detecting a SARS-CoV-2 antigen, in NPSs from 3 cohorts o...
Autores principales: | Fourati, Slim, Soulier, Alexandre, Gourgeon, Aurélie, Khouider, Souraya, Langlois, Camille, Galbin, Arnaud, Bouter, Anne Le, Rodriguez, Christophe, Joanny, Marie, Dublineau, Amélie, Challine, Dominique, Bouvier-Alias, Magali, Chevaliez, Stéphane, Audureau, Étienne, Pawlotsky, Jean-Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8628626/ https://www.ncbi.nlm.nih.gov/pubmed/34863056 http://dx.doi.org/10.1016/j.jcv.2021.105048 |
Ejemplares similares
-
Performance of 22 Rapid Lateral Flow Tests for SARS-CoV-2 Antigen Detection and Influence of “Variants of Concern”: Implications for Clinical Use
por: Gourgeon, Aurélie, et al.
Publicado: (2022) -
Performance of six rapid diagnostic tests for SARS-CoV-2 antigen detection and implications for practical use
por: Fourati, Slim, et al.
Publicado: (2021) -
Novel SARS-CoV-2 Variant Derived from Clade 19B, France
por: Fourati, Slim, et al.
Publicado: (2021) -
Hepatitis C Virus (HCV) Genotype 1 Subtype Identification in New HCV Drug Development and Future Clinical Practice
por: Chevaliez, Stéphane, et al.
Publicado: (2009) -
A novel standardized deep sequencing-based assay for hepatitis C virus genotype determination
por: Rodriguez, Christophe, et al.
Publicado: (2018)